Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature.
Angiosarcoma of the breast (AB) is a rare entity: its overall incidence is estimated at between 0.002% and 0.005% per year. Some potential risk factors have been described, mainly previous irradiation of the breast. We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussed.
Luini
Alberto
A
Division of Breast Surgery, European Institute of Oncology, via Ripamonti 435, 20141, Milan, Italy. alberto.luini@ieo.it
Gatti
Giovanna
G
Diaz
Jack
J
Botteri
Edoardo
E
Oliveira
Eliegina
E
Cecilio Sahium de Almeida
Rafaela
R
Veronesi
Paolo
P
Intra
Mattia
M
Pagani
Gianmatteo
G
Naninato
Paola
P
Viale
Giuseppe
G
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000532:radiotherapy; D018572:Disease-Free Survival; D005060:Europe; D005260:Female; D006394:Hemangiosarcoma / Q000175:diagnosis* / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D012509:Sarcoma / Q000175:diagnosis / Q000473:pathology / Q000532:radiotherapy; D012983:Soft Tissue Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000532:radiotherapy; D013997:Time Factors